SIK2 Maintains Breast Cancer Stemness by Phosphorylating LRP6 and Activating Wnt/β-Catenin Signaling

Researchers demonstrated a novel mechanism whereby Wnt/β-catenin signaling pathway was regulated by different kinases in response to metabolic requirement of CSCs, and suggest that SIK2 inhibition may potentially be a strategy for eliminating breast CSCs.